Episode 3: Improving Access, Affordability, and Adherence in Pharma with Conversational AI

 

During this episode of the Conversations with Orbita podcast, our host Nate Treloar is joined by Elise Whitaker, Orbita's VP Customer Success & Practice Lead, Pharmaceuticals & Life Sciences to talk about improving access, affordability, and adherence in Pharma with Conversational AI.

Where Automation Meets Empathy

Conversations with Orbita is a podcast sharing insights and innovations revolutionizing healthcare and life sciences with HIPAA-secure chat and voice-powered experiences empowered by conversational AI.

Introducing this episode's
guest, Elise Whitaker

Elise Whitaker

Elise has 20+ years of experience in developing and launching complex, custom, digital solutions for Fortune 500 companies within Advertising, Brand, UX, and AI firms. She has profound personal experiences that inspire her to bring conversational AI to the pharma space.

"Reach the individual on the device they are able to access and ideally, create some consistency in the experience of that virtual assistant, so that whether the user is using this Alexa-powered smart speaker or a smartphone or even talking over a conventional phone, they have the same access to information." -Treloar

"What pharma is really trying to help with right now, while many Americans are struggling, is to communicate to them and educate them of the different opportunities they have to get financial assistance." -Whitaker

Never miss a beat. 

Sign up for our blog, newsletter, and podcast updates and get information delivered straight to your inbox. 
Podcast Episode 3: Improving Access, Affordability, and Adherence in Pharma with Conversational AI

EPISODE RECAP

During this episode, host Nate Treloar discusses AI-powered solutions in pharma with Elise Whitaker, VP Customer Success & Practice Lead, Pharmaceuticals & Life Sciences at Orbita. The COVID-19 pandemic has compromised the access that millions have to healthcare and essential treatments. From asthma diagnoses to cancer, Elise and Nate explore the complexities around access, affordability, and adherence. What can pharma companies do to meet patients and HCPs where they are? How can conversational AI improve access? Join the conversation and learn more about financial assistance programs and new modules including adverse event detection features that empower pharma to embrace new technology.

Listening to this podcast episode, you'll gain insights on:

  • The disparities in how people manage and maintain their healthcare
  • The role of affordability in barring patients from acquiring healthcare, for example, out-of-pocket costs for cancer treatment alone can reach upwards of $30,000 per year
  • How pharmaceutical companies can inform patients about financial assistance programs
  • How to address the inequities of access, adherence, and affordability today

The implementation of conversational AI in pharmaceutical companies' patient and HCP contact points can deliver a wide-range of support. Episode 3 of the podcast explores how an intelligent virtual assistant can guide patients through their care treatment plans - how to use whatever equipment is required, what medication to take, and reminders of when to take care. Additionally, 24/7 on-demand chat and voice solutions are also powerful educators and can deliver financial resources, appointment scheduling support, and Q&A tools

Tune into the episode:

 
LISTEN TO MORE EPISODES OF THE CONVERSATIONS WITH ORBITA PODCAST

Related resources from Orbita

Podcast Episode 4 Orbitas COVID-19 Vaccine Access Clinical Program

Podcast Episode 4: Orbita's COVID-19 Vaccine Access Clinical Program

Nate Treloar is joined by Chelsea Biel, BSN, RN to discuss the COVID-19 vaccine rollout and more.

Podcast Episode 2 Whats Next for Healthcare Conversational AI?

Podcast Episode 2: What's Next for Healthcare Conversational AI?

In Episode 2, we're joined by CEO Bill Rogers to discuss predictions and expectations for the future of healthcare conversational AI. 

Can Pharma Transform the Patient Experience? New Ideas and Trends for Innovation

Can Pharma Transform the Patient Experience? New Ideas and Trends for Innovation

Hear from experts from Ogilvy, Roche, Janssen Pharmaceutical Companies of Johnson & Johnson, and Orbita.